PET Radiotracers of the Cardiovascular System

PET Clinics

Volumn 4, Issue 1, 2009, Pages 69-87

  Gropler, Robert J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow; Heart; Metabolism; Positron emission tomography; Radiotracers

Indexed keywords

3 (2 FLUOROETHYL)SPIPERONE F 18; 3 HYDROXYEPHEDRINE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 9 (4 FLUORO 3 HYDROXYMETHYLBUTYL)GUANINE; ACETIC ACID; ADENOSINE; ADRENALIN; AMMONIA; CARBON 11; CARBON MONOXIDE; DEOXYGLUCOSE; DIPYRIDAMOLE; DOPAMINE; FIALURIDINE; FLUORINE 18; GLUCOSE; GUANINE DERIVATIVE; LACTIC ACID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; OXYGEN 15; PALMITIC ACID; PALMITIC ACID DERIVATIVE; PHENYLEPHRINE; RUBIDIUM 82; TETROFOSMIN TC 99M; THALLIUM 201; TRACER; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER O 15;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CELL FUNCTION; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DRUG HALF LIFE; FALSE POSITIVE RESULT; GRAFT SURVIVAL; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART TRANSPLANTATION; HUMAN; IMAGE QUALITY; MEDICAL RESEARCH; NERVE CELL; NONHUMAN; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASODILATATION;

EID: 68349123640     PISSN: 15568598     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpet.2009.06.001     Document Type: Review

References (138)

1. Herrero P., Markham J., Shelton M.E., et al. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. Circ Res 70 (1992) 496-507
2. Lautamaki R., George R.T., Kitagawa K., et al. Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis. Eur J Nucl Med Mol Imaging 36 4 (2009) 576-586
3. Schelbert H.R., Phelps M.E., Huang S.C., et al. N-13 ammonia as an indicator or myocardial blood flow. Circulation 63 (1981) 1259-1272
4. Shah A., Schelbert H.R., Schwaiger M., et al. Measurement of regional myocardial blood flow with N-13 ammonia and positron-emission tomography in intact dogs. J Am Coll Cardiol 5 (1985) 92-100
5. Muzik O., Beanlands R.S., Hutchins G.D., et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 34 (1993) 83-91
6. Hutchins G.D., Schwaiger M., Rosenspire K.C., et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 15 5 (1990) 1032-1042
7. Gropler R.J., Siegel B.A., and Geltman E.M. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med 32 2 (1991) 245-251
8. Sun K.T., Yeatman A., Buxton D.B., et al. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11] acetate. J Nucl Med 39 2 (1998) 272-280
9. Yu M., Guaraldi M.T., Mistry M., et al. BMS-747158-02: a novel PET myocardial perfusion imaging agent. J Nucl Cardiol 14 6 (2007) 789-798
10. 18F-labeled myocardial perfusion tracer. J Nucl Med 49 4 (2008) 630-636
11. 13N-ammonia and validation with microspheres in a pig model. Circulation 119 17 (2009) 2333-2342
12. Kety S.S. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 3 (1951) 1-41
13. Kety S.S. Measurement of local blood flow by the exchange of an inert, diffusible substance. Methods Med Res 8 (1960) 228-236
14. Araujo L.I., Lammertsma A.A., Rhodes C.G., et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 83 (1991) 875-885
15. Bergmann S.R. Quantification of myocardial perfusion with positron emission tomography. In: Bergmann S.R., and Sobel B.E. (Eds). Positron emission tomography of the heart (1992), Futura, Mount Kisco (NY) 97-127
16. Bergmann S.R., Fox K.A., Rand A.L., et al. Quantification of regional myocardial blood flow in vivo with H215O. Circulation 70 (1984) 724-733
17. Bergmann S.R., Herrero P., Markham J., et al. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 14 (1989) 639-652
18. Tripp M.R., Meyer M.W., Einzig S., et al. Simultaneous regional myocardial blood flows by tritiated water in microspheres. Am J Physiol Heart Circ Physiol 232 (1977) H173-H190
19. Rahimtoola S.H. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72 (1985) V123-V135
20. Rahimtoola S.H. The hibernating myocardium. Am Heart J 117 (1989) 211-221
21. Conversano A., Walsh J.F., Geltman E.M., et al. Delineation of myocardial stunning and hibernation by positron emission tomgraphy in advanced coronary artery disease. Am Heart J 131 (1996) 440-450
22. Baller D., Notohamiprodjo G., Gleichmann U., et al. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 99 (1999) 2871-2875
23. Soto P.F., Herrero P., Baumstark J.M., et al. Endurance exercise training improves endothelial function in older individuals. [abstract]. Circulation 110 (2004) III-560
24. Hamasaki S., Suwaidi J.A., Higano S.T., et al. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 35 (2000) 1654-1660
25. Treasure C.B., Klein J.L., Vita J.A., et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 87 (1993) 86-93
26. Jorg-Ciopor M., Namdar M., Turina J., et al. Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myomectomy. J Thorac Cardiovasc Surg 128 2 (2004) 163-169
27. Rajappan K., Rimoldi O.E., Camici P.G., et al. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation 107 (2003) 3170-3175
28. Rechavia E., Araujo L.I., de Silva R., et al. Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 19 1 (1992) 100-106
29. Senneff M.J., Hartman J., Sobel B.E., et al. Persistence of coronary vasodilator reserve after cardiac transplantation. Am J Cardiol 71 4 (1993) 333-338
30. Krivokapich J., Stevenson L.W., Kobashigawa J., et al. Quantification of absolute myocardial blood flow at rest and during exercise with positron emission tomography after human cardiac transplantation. J Am Coll Cardiol 18 (1991) 512-517
31. Hickey K.T., Sciacca R.R., Bokhari S., et al. Assessment of cardiac wall motion and ejection fraction with gated PET using N-13 ammonia. Clin Nucl Med 29 (2004) 243-248
32. Sampson U.K., Dorbala S., Limaye A., et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 49 10 (2007) 1052-1058
33. Stewart R.E., Schwaiger M., Molina E., et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 67 16 (1991) 1303-1310
34. Bateman T.M., Heller G.V., McGhie A.I., et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 13 1 (2006) 24-33
35. Marwick T.H., Shan K., Patel S., et al. Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease. Am J Cardiol 80 7 (1997) 865-870
36. Schenker M.P., Dorbala S., Hong E.C., et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation 117 13 (2008) 1693-1700
37. 2 inhalation and positron emission tomography. Theory, error analysis, and application in humans. Circulation 94 4 (1996) 792-807
38. Laine H., Katoh C., Luotolahti M., et al. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation 100 24 (1999) 2425-2430
39. 2 inhalation and positron emission tomography. Experimental validation. Circulation 94 4 (1996) 808-816
40. Armbrecht J.J., Buxton D.B., and Schelbert H.R. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 81 5 (1990) 1594-1605
41. Brown M., Marshall D.R., Sobel B.E., et al. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 76 3 (1987) 687-696
42. Brown M.A., Myears D.W., and Bergmann S.R. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol 12 4 (1988) 1054-1063
43. Buck A., Wolpers H.G., Hutchins G.D., et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 32 10 (1991) 1950-1957
44. 18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med 32 4 (1991) 733-738
45. Gambert S., Vergely C., Filomenko R., et al. Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts. Mol Cell Biochem 283 1-2 (2006) 147-152
46. Iozzo P., Chareonthaitawee P., Di Terlizzi M., et al. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab 282 5 (2002) E1163-E1171
47. Krivokapich J., Huang S.C., Selin C.E., et al. Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. Am J Physiol 252 4 Pt 2 (1987) H777-H787
48. 18F]fluorodeoxyglucose. J Nucl Cardiol 4 2 Pt 1 (1997) 125-132
49. 18F]2-deoxy-2-fluoro-d-glucose for assessing myocardial glucose uptake. Circulation 91 9 (1995) 2435-2444
50. Hashimoto K., Nishimura T., Imahashi K.I., et al. Lumped constant for deoxyglucose is decreased when myocardial glucose uptake is enhanced. Am J Physiol 276 1 Pt 2 (1999) H129-H133
51. Herrero P., Sharp T.L., Dence C., et al. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET. J Nucl Med 43 11 (2002) 1530-1541
52. Herrero P., Weinheimer C.J., Dence C., et al. Quantification of myocardial glucose utilization by PET and 1-carbon-11-glucose. J Nucl Cardiol 9 1 (2002) 5-14
53. Herrero P., Kisrieva-Ware Z., Dence C.S., et al. PET measurements of myocardial glucose metabolism with 1-11C-glucose and kinetic modeling. J Nucl Med 48 6 (2007) 955-964
54. Herrero P., Dence C.S., Coggan A.R., et al. L-3-11C-lactate as a PET tracer of myocardial lactate metabolism: a feasibility study. J Nucl Med 48 12 (2007) 2046-2055
55. Bergmann S.R., Weinheimer C.J., Markham J., et al. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 37 10 (1996) 1723-1730
56. Davila-Roman V.G., Vedala G., Herrero P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40 2 (2002) 271-277
57. Herrero P., Peterson L.R., McGill J.B., et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol 47 3 (2006) 598-604
58. Peterson L.R., Herrero P., Schechtman K.B., et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109 18 (2004) 2191-2196
59. 18F]fluoro-6-thia-heptadecanoic acid (FTHA). J Labelled Comp Radiopharm 29 (1991) 989-995
60. 18F]fluoro-6-thia-heptadecanoic acid (FTHA): evaluation in mouse of a new probe of myocardial utilization of long chain fatty acids. J Nucl Med 32 10 (1991) 1888-1896
61. 18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPET. Nucl Med Commun 17 12 (1996) 1057-1064
62. 18F]FDG in patients with congestive heart failure. J Nucl Med 42 1 (2001) 55-62
63. DeGrado T.R., Wang S., Holden J.E., et al. Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation. Nucl Med Biol 27 3 (2000) 221-231
64. 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids. J Nucl Med 47 1 (2006) 173-181
65. 18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging. J Nucl Med 46 2 (2005) 297-304
66. Bing R.J. The metabolism of the heart. Harvey Lect 50 (1955) 27-70
67. Neely J.R., and Morgan H.E. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36 (1974) 413-459
68. Kelly D.P. PPARs of the heart: three is a crowd. Circ Res 92 5 (2003) 482-484
69. Finck B.N., Han X., Courtois M., et al. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci U S A 100 3 (2003) 1226-1231
70. Depre C., Shipley G.L., Chen W., et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 4 11 (1998) 1269-1275
71. Desrois M., Sidell R.J., Gauguier D., et al. Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart. J Mol Cell Cardiol 37 2 (2004) 547-555
72. Dyck J.R., and Lopaschuk G.D. Glucose metabolism, H+ production and Na+/H+-exchanger mRNA levels in ischemic hearts from diabetic rats. Mol Cell Biochem 180 1-2 (1998) 85-93
73. Peterson L.R., Soto P.F., Herrero P., et al. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 14 4 (2007) 573-581
74. Peterson L.R., Soto P.M., Herrero P., et al. Impact of gender on the myocardial metabolic response to obesity. JACC Cardiovasc Imaging 1 (2008) 424-433
75. Abu-Erreish G.M., Neely J.R., Whitmer J.T., et al. Fatty acid oxidation by isolated perfused working hearts of aged rats. Am J Physiol 232 3 (1977) E258-E262
76. McMillin J.B., Taffet G.E., Taegtmeyer H., et al. Mitochondrial metabolism and substrate competition in the aging Fischer rat heart. Cardiovasc Res 27 12 (1993) 2222-2228
77. Kates A.M., Herrero P., Dence C., et al. Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol 41 (2003) 293-299
78. Soto P.F., Herrero P., Schechtman K.B., et al. Exercise training impacts the myocardial metabolism of older individuals in a gender-specific manner. Am J Physiol Heart Circ Physiol 295 2 (2008) H842-H850
79. Lopaschuk G. Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J 139 2 Pt 3 (2000) S115-S119
80. Araujo L.I., Camici P., Spinks T.J., et al. Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography. Cardiovasc Drugs Ther 2 1 (1988) 41-46
81. 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 74 1 (1986) 81-88
82. He Z.X., Shi R.F., Wu Y.J., et al. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation 108 10 (2003) 1208-1213
83. Handa N., Magata Y., Mukai T., et al. Quantitative FDG-uptake by positron emission tomography in progressive hypertrophy of rat hearts in vivo. Ann Nucl Med 21 10 (2007) 569-576
84. de las Fuentes L., Herrero P., Peterson L.R., et al. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 41 1 (2003) 83-87
85. de las Fuentes L., Soto P.F., Cupps B.P., et al. Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency. J Nucl Cardiol 13 3 (2006) 369-377
86. Tuunanen H., Kuusisto J., Toikka J., et al. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study. J Nucl Cardiol 14 3 (2007) 354-365
87. Tuunanen H., Engblom E., Naum A., et al. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction. J Card Fail 12 8 (2006) 644-652
88. Commerford S.R., Pagliassotti M.J., Melby C.L., et al. Fat oxidation, lipolysis, and free fatty acid cycling in obesity-prone and obesity-resistant rats. Am J Physiol Endocrinol Metab 279 4 (2000) E875-E885
89. Zhou Y.T., Grayburn P., Karim A., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97 4 (2000) 1784-1789
90. Finck B.N., Lehman J.J., Leone T.C., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109 1 (2002) 121-130
91. Burkart E.M., Sambandam N., Han X., et al. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest 117 12 (2007) 3930-3939
92. Shoghi K.I., Gropler R.J., Sharp T., et al. Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation. J Nucl Med 49 8 (2008) 1320-1327
93. Herrero P., McGill J.B., Lesniak D., et al. Pet dection of the impact of dobutamine on myocardial glucose metabolism in women with type 1 diabetes mellitus. J Nucl Cardiol 15 6 (2008) 598-604
94. Hallsten K., Virtanen K.A., Lonnqvist F., et al. Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone. Diabet Med 21 12 (2004) 1280-1287
95. van der Meer R.W., Rijzewijk L.J., de Jong H.W., et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 119 15 (2009) 2069-2077
96. Ogawa M., Ishino S., Mukai T., et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 45 7 (2004) 1245-1250
97. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 23 (2002) 2708-2711
98. Tahara N., Kai H., Ishibashi M., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48 9 (2006) 1825-1831
99. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48 9 (2006) 1818-1824
100. Gropler R.J., and Bergmann S.R. Myocardial viability. What is the definition?. J Nucl Med 32 (1991) 10-12
101. Allman K.C., Shaw L.J., Hachamovitch R., et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 7 (2002) 1151-1158
102. Bax J.J., Poldermans D., Elhendy A., et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26 2 (2001) 141-186
103. DeGrado T.R., Hutchins G.D., Toorongian S.A., et al. Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine. J Nucl Med 34 (1993) 1287-1293
104. Caldwell J.H., Kroll K., Li Z., et al. Quantitation of presynaptic cardiac sympathetic function with carbon-11-meta-hydroxyephedrine. J Nucl Med 39 (1998) 1327-1334
105. Raffel D.M., Corbett J.R., del Rosario R.B., et al. Clinical evaluation of carbon-11-pheynylephrine: MAO-sensitive marker of cardiac sympathetic neruons. J Nucl Med 37 12 (1996) 1923-1931
106. 11C-hydroxyephedrine and positron emission tomography. Circulation 101 (2000) 516-523
107. 11C]epinephrine for routine PET studies in humans. Nucl Med Biol 20 (1993) 939-944
108. 11C]phenylephrine kinetics to monoamine oxidase activity in normal human heart. J Nucl Med 40 2 (1999) 232-238
109. Tipre D.N., and Goldstein D.S. Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med 46 11 (2005) 1775-1781
110. Elsinga P.H., van Waarde A., and Vaalburg W. Receptor imaging in the thorax with PET. Eur J Pharmacol 499 1-2 (2004) 1-13
111. 11C BG67, a novel radioligand for imaging myocardial alpha 1-adrenoreceptors with positron emission tomography. Eur J Nucl Med 27 (2000) 7-17
112. 11F]fluoroethoxybenzovesamicol as a new PET tracer of cholinergic neurons of the heart. Nucl Med Biol 21 (1994) 189-195
113. Delahaye N., Le Guludec D., Dinanian S., et al. Myocardial muscarinic receptor upregulation and normal respsonse to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation 104 (2001) 2911-2916
114. Le Guludec D., Delforge J., Syrota A., et al. In vivo quantification of myocardial muscarinic receptors in heart transplant patients. Circulation 90 (1994) 172-178
115. Le Guludec D., Cohen-Solal A., Delforge J., et al. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: an in vivo PET study. Circulation 96 (1997) 3416-3422
116. Allman K.C., Wieland D.M., Muzik O., et al. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronalo function after acute myocardial infarction in humans. J Am Coll Cardiol 22 (1993) 368-375
117. Bulow H.P., Stahl F., Lauer B., et al. Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. Nucl Med Commun 24 (2003) 233-239
118. Fallen E.L., Coates G., Nahmias C., et al. Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction. Am Heart J 137 (1999) 863-869
119. Bengel F.M., Ueberfuhr P., Ziegler S.I., et al. Non-invasive assessment of the effect of cardiac sympathetic innervation on metabolism of the human heart. Eur J Nucl Med 27 11 (2000) 1650-1657
120. Di Carli M.F., Tobes M.C., Mangner T., et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 336 (1997) 1208-1216
121. Bengel F.M., Ueberfuhr P., Schiepel N., et al. Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med 345 (2001) 731-738
122. Merlet P., Delforge J., Syrota A., et al. Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 87 (1993) 1169-1178
123. Pietila M., Malminiemi K., Ukkonen H., et al. Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med 28 3 (2001) 373-376
124. 11C-hydroxyephedrine PET, autonomic nervous control, and ventricular repolarization. J Nucl Med 43 6 (2002) 773-779
125. Calkins H., Allman K., Bolling S., et al. Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation 88 (1993) 172-179
126. Calkins H., Lehmann M.H., Allman K., et al. Scintigraphic pattern of regional cardiac sympathetic innervation in patients with familial long QT syndrome using positron emission tomography. Circulation 87 (1993) 1616-1621
127. 11C HED in genotyped long QT patients: a potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol 285 (2003) H1286-H1293
128. Schafers M., Lerch H., Wichter T., et al. Cardiac sympathetic innervation in patinets with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol 32 (1998) 181-186
129. Wichter T., Schafers M., Rhodes C.G., et al. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation 101 (2000) 1552-1558
130. Allman K.C., Stevens M.J., Wieland D.M., et al. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 22 (1993) 1425-1432
131. Di Carli M.F., Bianco-Batlles D., Landa M.E., et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100 (1999) 813-819
132. Stevens M.J., Dayanikli F., Raffel D.M., et al. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 31 (1998) 1575-1584
133. Stevens M.J., Raffel D.M., Allman K.C., et al. Cardiac sympathetic dysinnervation in diabetes. Circulation 98 (1998) 961-968
134. Stevens M.J., Raffel D.M., Allman K.C., et al. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism 48 (1999) 92-101
135. Schmid H., Forman L.A., Cao X., et al. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rates: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes 48 (1999) 603-608
136. Wu J.C., Chen I.Y., Sundaresan G., et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108 (2003) 1302-1305
137. Wu J.C., Inubushi M., Sundaresan G., et al. Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106 (2002) 180-183
138. Nahrendorf M., Zhang H., Hembrador S., et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117 3 (2008) 379-387